Hyperexpression of α-hemolysin explains enhanced virulence of sequence type 93 community-associated methicillin-resistant Staphylococcus aureus
- First Online:
- Cite this article as:
- Chua, K.Y., Monk, I.R., Lin, YH. et al. BMC Microbiol (2014) 14: 31. doi:10.1186/1471-2180-14-31
The community-associated methicillin-resistant S. aureus (CA-MRSA) ST93 clone is becoming dominant in Australia and is clinically highly virulent. In addition, sepsis and skin infection models demonstrate that ST93 CA-MRSA is the most virulent global clone of S. aureus tested to date. While the determinants of virulence have been studied in other clones of CA-MRSA, the basis for hypervirulence in ST93 CA-MRSA has not been defined.
Here, using a geographically and temporally dispersed collection of ST93 isolates we demonstrate that the ST93 population hyperexpresses key CA-MRSA exotoxins, in particular α-hemolysin, in comparison to other global clones. Gene deletion and complementation studies, and virulence comparisons in a murine skin infection model, showed unequivocally that increased expression of α-hemolysin is the key staphylococcal virulence determinant for this clone. Genome sequencing and comparative genomics of strains with divergent exotoxin profiles demonstrated that, like other S. aureus clones, the quorum sensing agr system is the master regulator of toxin expression and virulence in ST93 CA-MRSA. However, we also identified a previously uncharacterized AraC/XylS family regulator (AryK) that potentiates toxin expression and virulence in S. aureus.
These data demonstrate that hyperexpression of α-hemolysin mediates enhanced virulence in ST93 CA-MRSA, and additional control of exotoxin production, in particular α-hemolysin, mediated by regulatory systems other than agr have the potential to fine-tune virulence in CA-MRSA.
KeywordsStaphylococcus aureus CA-MRSA Pathogenesis Alpha-hemolysin
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging global problem with very similar clinical presentations across different clones, despite significant genetic diversity. Many CA-MRSA strains carry lukSF-PV in the accessory genome, which encodes the Panton-Valentine leukocidin (PVL), an exotoxin that causes neutrophil lysis. Although there has been considerable controversy as to the role of this toxin in CA-MRSA pathogenesis, some of this may be explained by a variable, species dependent susceptibility to PVL – human and rabbit neutrophils are lysed by PVL at very low concentrations whilst mouse and monkey neutrophils are less susceptible, making the interpretation of animal model data difficult in some cases. Additionally, the importance of PVL is also likely to be dependent on the site of infection. In the rabbit pneumonia model, PVL has been demonstrated to have a clear role in mediating severe lung necrosis and inflammation. In contrast, in skin infection, even in the rabbit model, its role remains less clear[4, 5].
Notwithstanding PVL, the increased expression of other core genome virulence determinants also contributes significantly to the increased virulence of CA-MRSA strains[6, 7]. These include α-hemolysin (Hla) and α-type phenol soluble modulins (PSMs). Hla is a pore-forming exotoxin that lyses many cells including red cells, platelets, monocytes and endothelial cells. Hla has been demonstrated to be an important mediator of virulence in skin infection and pneumonia[9, 10]. The α-type PSMs have been recently characterized and they lyse neutrophils and red cells[11, 12]. The α-type PSMs also mediate virulence in skin infection and septicemia and of these, PSMα3 is the most potent.
The study of unique, distantly related CA-MRSA clones that also demonstrate enhanced virulence, may provide insights into the emergence of the global CA-MRSA phenomenon, and also help define the genomic determinants of enhanced virulence. In Australia, the singleton ST93 CA-MRSA clone ST93 ("Queensland clone") has become dominant in the community, and we and others have demonstrated that our reference ST93 strain JKD6159 was highly virulent and caused severe skin infection in a mouse model compared to other CA-MRSA strains including USA300[14, 15].
In this study we used exotoxin analysis, functional genomics and a murine infection model to investigate the relative contribution of α-hemolysin, α-type phenol soluble modulins and Panton-Valentine leukocidin to the enhanced virulence of ST93 CA-MRSA. We show that increased virulence in the BALB/c mouse skin infection model is less dependent on α-type phenol soluble modulin or Panton-Valentine leukocidin production but is instead due to high-level expression of α-hemolysin in this clone, controlled predominantly by the agr system.
Results and discussion
The emergence of CA-MRSA is a major public health issue, and there is a clear need to understand the basis for both virulence and transmission of global clones of CA-MRSA. The genetically distinct CA-MRSA clone ST93-IV [2B] has rapidly become the dominant clone in Australia and its rise accounts for the increase in incidence of CA-MRSA as a whole in this country. We, and others have previously shown that ST93 strain JKD6159 is the most virulent global clone of S. aureus in murine models[14, 15]. To determine the mediators of virulence in this clone we initially studied exotoxin expression in a large collection of ST93 S. aureus from around Australia, and compared representative high and low expressing strains to an international selection of clones.
Exotoxin expression in ST93 CA-MRSA strains
Bacterial strains used in this study
S. aureus strain
Date of isolation
Place of isolation
Site of isolation
Dominant Australian CA-MRSA clone
Western Australia, Australia
Dominant Australian CA-MRSA clone
New South Wales, Australia
Australian CA-MRSA clone
Western Australia, Australia
Australian CA-MRSA clone
Australian CA-MRSA clone
Western Australia, Australia
Australian CA-MRSA clone
Australian CA-MRSA clone
San Francisco, USA
Dominant North American CA-MRSA clone
Dominant Australian hospital-associated MRSA clone, AUS2/3
Isogenic unmarked lukSF-PV KO of JKD6159
Isogenic unmarked hla KO of JKD6159. Deletion encompassed genome coordinates 1121291–1120441.
Isogenic unmarked hla KO repaired in JKD6159∆hla. Introduction of a novel PstI site within hla.
Isogenic unmarked psm-α KO in JKD6159. Deletion encompassed genome coordinates 453364–45378.
Isogenic unmarked psm-α KO repaired in JKD6159∆psm-α. Introduction of a novel SalI site within psm-α
Isogenic unmarked SAA6159_00043 KO of JKD6159. Deletion encompassed genome coordinates 53156 - 54561
Isogenic AraC/XylS regulator repaired in JKD6159
Isogenic agrA repair of TPS3105
As previously reported, PVL expression was consistent across most ST93 strains. We found that there was no significant difference in the LukF-PV expression in the PVL positive strains JKD6159, TPS3104, USA300 and JKD6177. Although USA300 appeared to produce less LukF-PV than JKD6159, the difference was not statistically significant (p = 0.0943, Figure 1A).
We found that the deformylated form of PSMα3 was almost always more abundant than the N-formylated form (Figure 1B and Additional file2). The ST30 CA-MRSA strain JKD6177 did not produce any PSMα3. There was no significant difference in PSMα3 expression between JKD6159 compared to USA300, however JKD6159 produced more PSMα3 compared to JKD6272 (p = 0.0003) and JKD6009 (p = 0.0003). Compared to the other ST93 MRSA strains, JKD6159 produced more PSMα3 compared to TPS3105 (p < 0.0001), and TPS3106 (p = 0.01) but less than TPS3104 (p = 0.0029) (Figure 1B). Expression levels across the whole ST93 collection were variable, although many isolates produced levels at least equivalent to USA300 (Additional file2).
Hla expression appeared high for the majority of ST93 isolates, with the exception of four strains where expression was low (Additional file3). JKD6159 produced greater levels of Hla than all the wildtype strains, including USA300 (p < 0.0001 for all strains except JKD6177, p = 0.0107, Figure 1C). There was no difference in Hla expression between JKD6159 and TPS3104.
Here we have demonstrated that the majority of ST93 strains consistently produce higher levels of Hla compared to other clones, including USA300, while production of PVL and α-type PSM is similar, suggesting that enhanced expression of Hla may be responsible for increased virulence of ST93 CA-MRSA.
Comparative virulence of ST93 isolates with differential exotoxin expression
Impact of exotoxin expression on virulence of ST93 CA-MRSA in the murine skin infection model
To further characterize the contribution of each of the exotoxins to disease in the murine model, genetic deletion and complementation experiments were performed for each of the selected toxins.
In order to determine the contribution of α-type PSMs to virulence of JKD6159, we generated JKD6159∆psmα (deletion of the whole α-type PSM locus) and assessed this mutant in the mouse skin infection assay (Figure 3). There was no significant difference in virulence in all outcome measures; weight loss (p = 0.06), lesion size (p = 0.8174) and CFU recovery (p = 0.1925). The absence of PSMα3 production was verified by HPLC and the integrity of the JKD6159∆psmα was confirmed by complementation (Additional file5). It is noteworthy that the level of expression of PSMα3 by JKD6159 was similar to USA300 (Figure 1), a strain that produces high levels of PSMs and where a contribution to virulence has been demonstrated[7, 11]. Despite this, the deletion mutant (JKD6159∆psmα) demonstrated no attenuation of virulence compared to JKD6159 (Figure 3). The significantly divergent genetic background of ST93 compared with USA300 may account for this difference in the importance of α-type PSMs to the virulence of JKD6159.
We constructed an isogenic PVL negative mutant in JKD6159 by deleting lukSF-PV. Western Blot analysis confirmed the absence of LukF-PV in the mutant (Additional file6). Assessment of the JKD6159ΔlukSF-PV mutant in the mouse skin infection model showed no decrease in virulence (Figure 3). Therefore PVL was not contributing to the increased virulence in JKD6159 in this murine model. Murine neutrophils, unlike rabbit and human neutrophils are relatively resistant to the effects of PVL so it is difficult to draw firm conclusions as to the human importance of this result. However, the aim of this study was to uncover the mechanisms for the observed increased virulence of ST93 previously demonstrated using this mouse model. Our results reinforce the results of others who have examined different S. aureus clones which indicate that Hla, rather than PVL is the main mediator of virulence in CA-MRSA in a mouse skin infection model[9, 10, 21, 22]. It should be noted that other authors have concluded that the rabbit skin infection model gave very similar results to the mouse model for infection at the same site. Nonetheless, testing of our PVL deletion mutant in a rabbit model may be warranted in future.
Genome sequencing of three additional ST93 isolates
Comparative genomics of ST93 and the importance of agr in the virulence of ST93 CA-MRSA
We next explored the contribution of specific mutations to the differential virulence of the ST93 strains. Using our read mapping approach described above, we compared the genome sequences of TPS3104, TPS3105 and TPS3106 with each other and with JKD6159. There were a number of single nucleotide polymorphisms (SNPs) and insertions and deletions (indels) differentiating the strains from JKD6159 (Additional files8,9,10). We searched for mutations in regulatory genes that could potentially explain the different virulence phenotypes of the strains. Notably, both avirulent ST93 strains, TPS3105 and TPS3106 contained mutations within the agr locus. We have since completed whole genome sequencing of TPS3151 and TPS3161 and found they contain predicted amino acid substitutions in AgrC that might disrupt agr function (Stinear et al., submitted). These isolates demonstrated low expression of Hla (Additional file3).
Additionally, TPS3106 also contained a mutation in a gene encoding a previously uncharacterized AraC/XylS family regulatory protein. This was also of particular interest as members of this class have been shown to contribute to the regulation of exotoxin expression[24, 25].
The AraC/XylS regulator (AryK) enhanced Hla expression and virulence in ST93 CA-MRSA
The SNP at position 92551 in SAA6159_00084 introduced a premature stop codon and created a pseudogene within SAA6159_00084 in JDK6159, however the gene was intact in TPS3106. The intact version of this gene, which was also intact in 19 other publically available S. aureus genome sequences we examined, encodes a previously uncharacterized AraC/XylS family regulatory protein. While the virulence attenuation in TPS3106 was likely a direct result of the agr deficiency, we also wanted to determine if the novel regulator mutation in SAA6159_00084 impacted the virulence in ST93 S. aureus.
To test the hypothesis that SAA6159_00084 encoded a regulator of virulence, we repaired the premature stop codon in SAA6159_00084 in JKD6159 using allelic exchange to generate strain JKD6159_AraCr. To confirm we had not introduced additional DNA changes during allelic exchange we sequenced the whole genome of JKD6159_AraCr and found no additional mutations (35× coverage). JKD6159_AraCr encoding an intact copy of SAA6159_00084 demonstrated a modest, but significant increase in virulence as indicated by lesion size (p < 0.0001) and weight loss in the mouse skin infection assay (p = 0.0311, Figure 5), suggesting that this protein is a positive regulator of virulence in CA-MRSA strains. JKD6159_AraCr expressed more PSMα3 (p = 0.0325) and Hla (p = 0.0473) than its parental strain JKD6159 that was consistent with an increase mouse skin lesion size (Figure 6). We propose the name aryK for SAA6159_00084 (Ar aC family-lik e gene).
RNAseq demonstrates global regulatory impact of AryK
Here, we have clearly demonstrated that agr is the major "on-off" switch for virulence in ST93 CA-MRSA, but we also found that other genetic changes are impacting virulence gene regulation in a clone-specific manner. We speculate that the inactivation of aryK may have been an evolutionary response by ST93 CA-MRSA to modulate or fine-tune the amount of Hla and other factors required for host persistence. There are six AraC/XylS family regulators in S. aureus (SA0097, SA0215, SA0622, SA1337, SA2092, SA2169; S. aureus strain N315 locus tags). Two of these, Rbf (SA0622) and Rsp (SA2169) have been studied and demonstrated in other S. aureus strains to regulate biofilm formation and modulate expression of surface-associated proteins[24, 25, 31]. In contrast, we found that aryK increases Hla expression and virulence, acting as a positive regulator of virulence by directly or indirectly upregulating exotoxin expression, without an apparent effect on agr expression in stationary phase.
In this study, we have obtained insights into the genetic basis for the increased virulence of ST93 by using a combination of comparative and functional genomics. We have demonstrated the key role of Hla and agr and shown how an additional novel regulatory gene, aryK by a loss-of-function point mutation, is modulating virulence in this clone. Quantification of exotoxin expression in a larger collection of ST93 strains demonstrated that the findings in strain JKD6159 are relevant to the majority of the ST93 population isolated from around Australia as exotoxin expression in JKD6159 is representative of most of the ST93 population. Our study highlights the power of comparative genomics to uncover new regulators of virulence but it also shows the complex nature of these changes even in closely related bacterial populations. Careful strain selection, detailed comparative genomics analyses, and functional genomic studies by creating multiple genetic changes in one strain will be required to gain a full insight into the genetic basis for the emergence and hypervirulence of ST93 CA-MRSA.
This study was performed in accordance with the Australian Prevention of Cruelty to Animals Act 1986 and the Australian code of practice for the care and use of animals for scientific purposes. The protocol was approved by the Animal Ethics Committee of the University of Melbourne (Permit Number: 0911248.2).
Bacterial strains and culture
Bacterial strains used in this study are summarized in Table 1 (international clone collection) and Additional file1 (ST93 strain collection), and include the ST93 reference strains JKD6159, USA300 strain FPR3757, ST30 strain JKD6177, and the HA-MRSA ST239 clone JDK6009, as well as 58 additional ST93 collected from around Australia and previously reported. For all experiments except exotoxin expression bacteria were grown in brain heart infusion broth (BHI, Oxoid). For the mouse skin infection assay, S. aureus were harvested at the stationary phase of growth after 18 hours incubation (OD600 ~ 2.0), washed, diluted and resuspended in PBS. The bacterial inoculum (CFU) and viable counts were determined by plating onto BHI agar and colony enumeration.
For LukF-PV expression experiments, bacteria were grown in CCY media (3% yeast extract (Oxoid), 2% Bacto Casamino Acids (Difco), 2.3% sodium pyruvate (Sigma-Aldrich), 0.63% Na2HPO4, 0.041% KH2PO4, pH 6.7). For α-hemolysin (Hla) and PSMα3 expression experiments, bacteria were grown in tryptone soy broth (TSB, Oxoid). Overnight cultures were diluted 1:100 into fresh media and then incubated at 37°C with shaking (180 rpm) until stationary phase was achieved. For LukF-PV detection, isolates were cultured for 8 hours (OD600 ~ 1.8); for Hla detection, isolates were cultured for approximately 3 hours (OD600 ~ 1.8); and for PSMα3 detection, isolates were cultured for 24 hours (OD600 ~ 2.0). Culture supernatants were harvested by centrifugation and filter sterilized. These were performed in at least triplicate for each S. aureus strain.
Detection of LukF-PV and Hla by western blotting
Trichloroacetic acid was added to culture supernatants and incubated at 4°C overnight. Precipitates were then harvested by centrifugation, washed with acetone, air-dried and solubilized in a SDS and 2-mercaptoethanol containing sample buffer. The proteins were separated on 12% SDS-PAGE. A peptide sequence specific to LukF-PV, HWIGNNYKDENRATHT was synthesized and HRP conjugated polyclonal chicken IgY was raised against this peptide (Genscript). This antibody was used to detect LukF-PV with enhanced chemiluminescence. Images generated from the western blots were quantitated using GS800 Calibrated Densitometer (BioRad) and Image J.
Hla was detected using a polyclonal rabbit anti-Hla (Sigma-Aldrich), in buffer containing 20 mM DEPC to inhibit non-specific protein A binding and HRP conjugated sheep anti-rabbit secondary antibody (Millipore) with enhanced chemiluminescence detection. For comparison of JKD6159 versus international clone collection (Table 1), images generated from the Hla western blots were quantitated using GS800 Calibrated Densitometer (BioRad) and Image J.
Subsequently, for comparison of JKD6159 and other ST93 strains (Table 1), detection of chemiluminescence was performed using the MF-ChemiBIS 3.2 platform (DNR Bioimaging systems). Quantitation was performed using Image J.
Detection of PSMα3 expression
HPLC chromatography was performed on an Agilent Technology 1200 Series system with an analytical Agilent Eclipse XDB-C18 (4.6 mm × 150 mm) column. A water/acetonitrile gradient (0.1% trifluoroacetic acid) from 0 – 100% acetonitrile over 28 min at a flow rate of 1 mL/min was used. The total run time was 32 min, and peaks were quantified at a wavelength of 214 nm. The deformylated and formylated form of PSMα3 MEFVAKLFKFFKDLLGKFLGNN was identified in the S. aureus TSB culture supernatants by comparison of their retention times to a commercially synthesized PSMα3 standard (GenScript) and by spiking the samples with the synthesized standards. The identity of the deformylated peptide present in the samples was confirmed by analysing collected fractions by ESI-MS. There was only one peptide present in this fraction; the deformylated form of PSMα3. In contrast, other peptides were observed in the fractions of USA300, JKD6272, TPS3104, TPS3105r, and JKD6159_AraCr containing the N-formylated form of PSMα3. In these cases, the percentage of N-formylated PSMα3 peptide was determined using the total ion count of the major peaks in the ESI-MS and the peak area of the HPLC chromatogram was adjusted accordingly. The concentrations of the deformylated and formylated forms of PSMα3 were determined by comparison of their peak areas to those of the synthesized standards. The standard curves were constructed in the concentration range of 6.2 – 100 μg/ mL and were linear over this range.
DNA methods, molecular techniques and construction of mutants
DNA was extracted using the GenElute kit according to the manufacturer’s instructions (Sigma-Aldrich). A lukSF-PV knockout, hla knockout and a repaired agrA of TPS3105 were generated according to the published method. For the knockouts, flanking sequences were amplified and ligated prior to cloning with pKOR1. For allelic replacement to generate TPS3105r, a PCR product of agrA from JKD6159 was cloned with pKOR1. For allelic replacement JKD6159_AraCr, a PCR product of this AraC regulator from TPS3106 was cloned with pKOR1. The deletion of the whole psmα locus in JKD6159, chromosomal restoration of psmα in JKD6159∆psmα and the restoration of Hla expression in JKD6159∆hla were conducted using the pIMAY protocol described by Monk et al.. Knockout and restoration amplimers were cloned into pIMAY by SLIC. The primers used are listed in Additional file11. The knockout and restoration clones were confirmed by PCR and Sanger sequencing of the mutated locus. Mutations were further validated with functional assays of activity, which included sheep blood hemolysis, western blot, and/or HPLC.
Mouse skin infection assay
Mice were infected with S. aureus as previously described. Briefly, six-week-old female BALB/c mice were infected by intradermal injection with 108 CFU of S. aureus. Mice were assessed and weighed daily for five days. Mice were culled on the 5th day and lesion size measured and CFU recovered from infected tissues by homogenization and colony enumeration on BHI. For each S. aureus strain, at least 10 mice were assessed.
Genome sequences for three ST93 strains (TPS3104, TPS3105, TPS3106) were obtained from an Illumina GAIIx analyzer using 100 bp paired-end chemistry with a mean fold coverage of 331×. Genome sequencing of the two laboratory-induced mutants JKD6159∆hla (TPS3265) and JKD6159_AraCr (TPS3268) was performed using Ion Torrent sequencing technology.
A read mapping approach was used to compare the sequences from all isolates used in this study, as previously described[14, 37]. Briefly, the reads from all genomes were aligned to the JKD6159 reference using SHRiMP 2.0. SNPs were identified using Nesoni v0.60 [http://www.bioinformatics.net.au]. Using the whole genome sequence of JKD6159 as a reference, a global SNP analysis was performed, and allelic variability at any nucleotide position was tallied to generate a global SNP analysis for every genome compared to JKD6159.
Quantitative RT-PCR for RNAIII expression
To investigate activity of the agr locus (RNAIII) qRT-PCR was performed for RNAIII as previously described. Briefly, RNA was prepared as previously described with two on-column DNase I digestion steps and cDNA synthesis using SuperScript II reverse transcriptase (Invitrogen). Relative expression was determined as previously described and was normalised against gyrB. Results were obtained from 3 biological replicates each performed in triplicate.
Staphylococcus aureus strains JKD6159 and JKD6159_AraCr were grown to early stationary culture as described above. For RNA protection, 0.5 volumes of RNAlater® RNA stabilization reagent (Qiagen) was added immediately to the liquid culture and allowed to incubate with the bacterial suspension for 15 minutes at room temperature. Cells were pelleted at 5,000 × g for 5 minutes followed by RNA extraction using RNeasy mini kit (Qiagen) and two rounds of DNase I digestion (Qiagen) according to the manufacturer’s instruction. RNA concentration was quantified using Qubit® 2.0 Fluorometer and RNA quality assessed using Agilent 2100 Bioanalyzer. Ten μg of total RNA from the stationary growth phase with RNA intergrity number (RIN) greater than 7 was used in RNA-seq. Ribosomal depletion, cDNA library preparation and pair ended sequencing using HiSeq2000 sequencing platform was performed by Beijing Genome Institute (Hong Kong, China). RNAseq was performed on two biological samples for each strain.
RNAseq reads were mapped onto the JKD6159 reference genome, using SHRiMP 2.2.2. Alignment to CDS features from each biological replicate of each strain provided counts that were a measure of mRNA levels. Counts were normalized using the trimmed-mean normalization function in edgeR, part of the BioConductor package. A heat map was created based on log2 transformed counts to identify consistent changes in expression profiles between strains. To be included in the heat map, genes were required to have at least 1000 counts, totaled over all samples, where and the standard deviation of the log2 expression levels had to exceed two.
Percentage mouse weight change at day 5, viable counts of S. aureus in mouse tissues and skin lesion area of each isolate, Hla, LukF-PV and PSMα3 expression versus JKD6159 were analyzed using an unpaired t test. A similar analysis was used to analyze virulence outcome measures and exotoxin expression between TPS3105 and TPS3105r. (There was no difference in results when Bonferonni analysis was performed). All analyses were performed using Prism 5 for Macintosh v5.0b (GraphPad Software Inc.).
Availability of supporting data
The data sets supporting the results of this article are in the NCBI Sequence Read Archive under study accession SRP004474.2 and the NCBI BioProject Archive under study accession PRJNA217697.
Timothy P. Stinear and Benjamin P. Howden are the Joint Senior Authors.
We thank Kirstie Mangas and Brian Howden for expert technical assistance.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.